A citation-based method for searching scientific literature

C A Jones, D J G Watson, K C F Fone. Br J Pharmacol 2011
Times Cited: 428







List of co-cited articles
968 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
13

An Overview of Animal Models Related to Schizophrenia.
Ian R Winship, Serdar M Dursun, Glen B Baker, Priscila A Balista, Ludmyla Kandratavicius, Joao Paulo Maia-de-Oliveira, Jaime Hallak, John G Howland. Can J Psychiatry 2019
48
25

The environment and schizophrenia.
Jim van Os, Gunter Kenis, Bart P F Rutten. Nature 2010
870
10


Glutamate and dopamine in schizophrenia: an update for the 21st century.
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
385
9

Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
P Steullet, J-H Cabungcal, J Coyle, M Didriksen, K Gill, A A Grace, T K Hensch, A-S LaMantia, L Lindemann, T M Maynard,[...]. Mol Psychiatry 2017
166
9

Altering the course of schizophrenia: progress and perspectives.
Mark J Millan, Annie Andrieux, George Bartzokis, Kristin Cadenhead, Paola Dazzan, Paolo Fusar-Poli, Jürgen Gallinat, Jay Giedd, Dennis R Grayson, Markus Heinrichs,[...]. Nat Rev Drug Discov 2016
260
9

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.
Daniela Cadinu, Ben Grayson, Giovanni Podda, Michael K Harte, Nazanin Doostdar, Joanna C Neill. Neuropharmacology 2018
78
10

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Joanna C Neill, Samuel Barnes, Samantha Cook, Ben Grayson, Nagi F Idris, Samantha L McLean, Shikha Snigdha, Lakshmi Rajagopal, Michael K Harte. Pharmacol Ther 2010
372
8

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms.
Robert A McCutcheon, Anissa Abi-Dargham, Oliver D Howes. Trends Neurosci 2019
180
8

GABAergic interneuron origin of schizophrenia pathophysiology.
Kazu Nakazawa, Veronika Zsiros, Zhihong Jiang, Kazuhito Nakao, Stefan Kolata, Shuqin Zhang, Juan E Belforte. Neuropharmacology 2012
308
8

Animal models of neuropsychiatric disorders.
Eric J Nestler, Steven E Hyman. Nat Neurosci 2010
7



Rethinking schizophrenia.
Thomas R Insel. Nature 2010
7

NMDAR Hypofunction Animal Models of Schizophrenia.
Gloria Lee, Yi Zhou. Front Mol Neurosci 2019
40
17


Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
7

Schizophrenia: a concise overview of incidence, prevalence, and mortality.
John McGrath, Sukanta Saha, David Chant, Joy Welham. Epidemiol Rev 2008
7

Schizophrenia risk from complex variation of complement component 4.
Aswin Sekar, Allison R Bialas, Heather de Rivera, Avery Davis, Timothy R Hammond, Nolan Kamitaki, Katherine Tooley, Jessy Presumey, Matthew Baum, Vanessa Van Doren,[...]. Nature 2016
6


Schizophrenia.
René S Kahn, Iris E Sommer, Robin M Murray, Andreas Meyer-Lindenberg, Daniel R Weinberger, Tyrone D Cannon, Michael O'Donovan, Christoph U Correll, John M Kane, Jim van Os,[...]. Nat Rev Dis Primers 2015
371
6

The neurodevelopmental hypothesis of schizophrenia, revisited.
S Hossein Fatemi, Timothy D Folsom. Schizophr Bull 2009
479
6


Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience.
J P Kesby, D W Eyles, J J McGrath, J G Scott. Transl Psychiatry 2018
104
6

Cortical inhibitory neurons and schizophrenia.
David A Lewis, Takanori Hashimoto, David W Volk. Nat Rev Neurosci 2005
5

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.
Kuei Y Tseng, R Andrew Chambers, Barbara K Lipska. Behav Brain Res 2009
240
5

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.
Patrick F Sullivan, Kenneth S Kendler, Michael C Neale. Arch Gen Psychiatry 2003
5

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
Vera Bubeníková-Valesová, Jirí Horácek, Monika Vrajová, Cyril Höschl. Neurosci Biobehav Rev 2008
220
5


Cerebral organoids model human brain development and microcephaly.
Madeline A Lancaster, Magdalena Renner, Carol-Anne Martin, Daniel Wenzel, Louise S Bicknell, Matthew E Hurles, Tessa Homfray, Josef M Penninger, Andrew P Jackson, Juergen A Knoblich. Nature 2013
5

Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801.
A M Bygrave, S Masiulis, E Nicholson, M Berkemann, C Barkus, R Sprengel, P J Harrison, D M Kullmann, D M Bannerman, D Kätzel. Transl Psychiatry 2016
55
9


Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.
Yavuz Ayhan, Ross McFarland, Mikhail V Pletnikov. Prog Neurobiol 2016
48
10

Schizophrenia.
Kim T Mueser, Susan R McGurk. Lancet 2004
565
5

Provocative tests with psychostimulant drugs in schizophrenia.
J A Lieberman, J M Kane, J Alvir. Psychopharmacology (Berl) 1987
367
5

The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
556
5

The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
Oliver D Howes, Robert McCutcheon, Michael J Owen, Robin M Murray. Biol Psychiatry 2017
227
5


Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.
Christina Wilson, Alvin V Terry. Clin Schizophr Relat Psychoses 2010
43
11


New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
Avia Merenlender-Wagner, Zeev Shemer, Olga Touloumi, Roza Lagoudaki, Eliezer Giladi, Annie Andrieux, Nikolaos C Grigoriadis, Illana Gozes. Autophagy 2014
46
10



Schizophrenia.
Michael J Owen, Akira Sawa, Preben B Mortensen. Lancet 2016
717
5

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
Joanna C Neill, Michael K Harte, Peter M Haddad, Emma S Lydall, Dominic M Dwyer. Eur Neuropsychopharmacol 2014
83
6

Sex differences in schizophrenia.
Kathryn M Abel, Richard Drake, Jill M Goldstein. Int Rev Psychiatry 2010
395
5

Schizophrenia, "just the facts" 4. Clinical features and conceptualization.
Rajiv Tandon, Henry A Nasrallah, Matcheri S Keshavan. Schizophr Res 2009
559
5

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.
C S Weickert, S J Fung, V S Catts, P R Schofield, K M Allen, L T Moore, K A Newell, D Pellen, X-F Huang, S V Catts,[...]. Mol Psychiatry 2013
160
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.